Skip to main content
. 2021 Feb 10;12:599778. doi: 10.3389/fphar.2021.599778

TABLE 1.

Antifungal activities of two extracts of R. przewalskii.

Fungi AERP (inhibition rates %) EERP (inhibition rates %) Ketoconazole (MIC mg/mL) Azoxystrobin (inhibition rates %)
5 mg/ml 2 mg/ml 5 mg/ml 2 mg/ml 0.1 mg/ml
A. niger ND 1 ND ND ND 0.025
S. cerevisiae ND ND ND ND 0.013
C. albicans ND ND ND ND 0.025
B. cinerea 9.99 ± 1.25 aa 2.40 ± 0.78 aa 4.40 ± 1.11 aa ND 59.51 ± 1.34
M. oryzae 24.94 ± 2.43 aa 11.12 ± 1.11 aa 27.96 ± 3.25 aa 21.39 ± 5.34 aa 84.82 ± 4.87
P. cyclopium 17.03 ± 1.23 aa 13.11 ± 2.01 aa 24.21 ± 3.45 aa 13.66 ± 3.28 aa 80.06 ± 5.34
R. stolonifer 13.95 ± 0.95 aa 6.19 ± 0.56 aa 3.65 ± 1.23 aa ND 84.63 ± 2.46
R. solani 10.88 ± 2.67 aa 6.21 ± 1.23 aa 5.94 ± 2.13 aa ND 30.41 ± 3.26
S.sclerotiorum 67.04 ± 4.91 bb 47.11 ± 3.25 ND ND 34.94 ± 2.35
a

ND represents compounds did not show the inhibitory activity against fungi at the concentration of 5 mg/ml.

aa

Represents p < 0.01, the antifungal activity of extracts were significant weaker compared positive control azoxystrobin, ANOVA with Dunnett`s multiple comparisons test.

bb

Represents p < 0.01, the antifungal activity of extracts were significant stronger compared positive control azoxystrobin, ANOVA with Dunnett`s multiple comparisons test.